Increasing Lung Cancer Screening in the Emergency Department

This study is looking at ways to help more people get screened for lung cancer, especially those who visit the emergency department (ED). It's testing two approaches: a "Basic Referral" where you get written information and a phone number for a lung cancer screening (LCS) program, and a "Facilitated Referral and Text Messaging" approach. In the second approach, the LCS program will contact you directly to discuss screening and schedule it, plus you'll receive text message reminders. The study wants to see if these methods can increase the number of people who get screened for lung cancer. You might be able to join if you are 50-80 years old, have a significant smoking history, speak English, and are a current patient in a URMC-involved ED. The study's status is unclear.

Study design
This is an interventional study that plans to enroll 349 participants. Participants will be randomly assigned to one of two groups.
What's involved
If you join, you will either receive written materials and a phone number for the LCS program, or the LCS program will contact you directly and you will receive text messages to encourage screening.
Compensation
Not stated in the trial record.
Follow-up
The study will assess lung cancer screening uptake and downstream care from enrollment through participation, with the first assessment around 120 days.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07287085

Increasing Lung Cancer Screening Uptake Among Emergency Department Patients

Recruiting
NAAges 50–80InterventionalScreening
University of Rochester
~349 participants
Updated 2026-05-04 on ClinicalTrials.gov
What's tested:Facilitated referral and text messagingBasic Referral (enhanced control arm)

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Assessment for LCS Uptake and Downstream Care
Measured over From enrollment through participation with first assessment at ~ 120 days of participation.
Screening Compliance
Lung Cancer (Diagnosis)
Lung Cancer Diagnosis
Lung Cancer
1 sites across 1 states
New York1

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age 50 - 80
≥ 20 pack-year smoking history
current smoker or quit within 15 years
English speaking
Current patient in URMC involved Emergency Department

Exclusion

Non-English
Inability to provide consent (e.g. high clinical acuity, cognitive deficit)
Lack of text-capable mobile phone and/or inability to use text function
Not being a patient in URMC involved Emergency Department There are no restrictions for gender, racial and ethnic origins.
  • Assessment for LCS Uptake and Downstream CareFrom enrollment through participation with first assessment at ~ 120 days of participation.

    The primary outcome, LCS uptake, will be assessed via telephone follow-up and EHR review.